NEW YORK (GenomeWeb) – Oxford Nanopore said this week that it has opened the PromethIon Early Access Program (PEAP) to allow researchers to get first access to the technology. The PromethIon is a desktop device for high-throughput, high-sample number, nanopore-based analysis of DNA and RNA. It works the same way as Oxford's MinIon, the company said, but on a larger scale. PEAP participants will receive a PromethIon, installation support, flow cells, and reagent kits, and access to online support communities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.